Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market Outlook to 2023: Rise in the Miniaturization of Nucleic Acid-based Diagnostics - ResearchAndMarkets.com
Aug. 27, 2018
DUBLIN--(BUSINESS WIRE)--Aug 27, 2018--The "Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market - Segmented by Technology, Application, and Geography - Growth, Trends, and Forecast (2018 - 2023)" report has been added to ResearchAndMarkets.com's offering.
The global isothermal nucleic acid amplification technology (INAAT) market is expected to register a CAGR of 10.5%, during the forecast period, (2018-2023).
Rise in the Miniaturization of Nucleic Acid-based Diagnostics
Miniaturization of biochemical reactions leads to major advantages, where a lower amount of valuable clinical sample and reagents is just one: approximately 1/1000 of the volume used in conventional lab setups has been shown to obtain a similar result. A smaller heat capacity allows for rapid changes in temperature beneficial for the PCR time, as well as a higher parallelism of multiple genetic samples.
The benefit of isothermal amplification methods compared to PCR is the constant temperature of amplification. This will result in a high potential for a simple integration in point-of-care devices and a reduction of complexity.
With increasing demand of low cost and effective solutions for diagnosis of diseases and increasing demand for point of care applications, these devices are going to witness growth in the future.
Also in case of laboratories the sample size required is very small which also helps in reducing the amount of reagents required. Also, the upsurge in the molecular diagnostics market, increasing incidences of chronic diseases and aging population, and increase in the adoption of INAAT over PCR are driving the market growth.
Key HighlightsStringent Regulatory Framework North America to Dominate the Market
Notable DevelopmentsAlere Inc., a global leader in rapid diagnostic tests, announced that the U.S. Food and Drug Administration (FDA) has granted CLIA waiver for the Alere i Strep A test.
Key Topics Covered
2. Research Methodology
3. Executive Summary
4. Key Inferences
5. Market Overview
6. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
7. Market Segmentation
8. Competitive Landscape
9. Key PlayersAlere Becton, Dickinson & Company Biomeriux Hologica Lucigen Quidel Corporation New England Biolabs Nugen Qiagen Ustar Biotechnologies
10. Future of the Market
For more information about this report visit https://www.researchandmarkets.com/research/x4ghkn/global_isothermal?w=4
View source version on businesswire.com:https://www.businesswire.com/news/home/20180827005353/en/
Laura Wood, Senior Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics:Molecular Diagnostics
INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY OTHER SCIENCE SCIENCE
SOURCE: Research and Markets
Copyright Business Wire 2018.
PUB: 08/27/2018 10:06 AM/DISC: 08/27/2018 10:06 AM